A linear model for the pharmacokinetics of azithromycin in healthy volunteers

Chemotherapy

Volumn 42, Issue 6, 1996, Pages 402-409

  Ripa, Sandro ^a   Ferrante, L ^b   Prenna, M ^a  

^a UNIVERSITY OF CAMERINO   (Italy)

^b UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

Azithromycin; Pharmacokinetics; Zero order absorption

Indexed keywords

AZITHROMYCIN; MACROLIDE;

ADULT; ARTICLE; COMPARTMENT MODEL; DRUG ABSORPTION; DRUG DISPOSITION; DRUG ELIMINATION; HUMAN; HUMAN EXPERIMENT; MEAN RESIDENCE TIME; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; STATISTICAL MODEL;

EID: 0029817185     PISSN: 00093157     EISSN: 14219794     Source Type: Journal    
DOI: 10.1159/000239473     Document Type: Article

References (18)

1. Bright GM, Nagel AA, Bordner J: Synthesis, in vitro and in vivo activity of novel 9-deoxo-9a-aza-9a homoerythromycin a dcrivate: A new class of macrolide antibiotics, the azalidcs. J Antibiot (Tokio) 1988; 41:1029-1047.
2. Rctzema J, Girard A, Schelkly W, et al: Spectrum and mode of action of azithromycin (CP 62993), a new 15-membered-ring macrolide with improved potency against gram-negative organisms. Antimicriob Agents Chemother 1987;31:1937-1947.
3. Rylander M, Hallandcr HO: In vitro comparison of the activity of doxi-cycline, tetracycline, erythromycin and a new macrolide CP-62, 993 against Mycoplasma pneumoniae, Mycoplasma liominis and Ureaplasma urealyticum. Scand J Dis 1990; 53 (suppl): 39-47.
4. Ficsc EF, Steffen SH: Comparison of the acid stability of azithromycin and erythromycin A. Antimicrob Chemother 1990;25(suppl A):39-47.
5. Girard AE, Girard D, English AR, Gootz TD, Cimochowski CR, Haskell JL, Retsema JA: Pharmacokinetics and in vivo studies with azithromycin (CP-62,993), a new macrolide with an extended half-life and excellent tissue distribution. Antimicrob Agents Chemother 1987;31:1948-1954.
6. Shepard RM, Duthu GS, Ferraina RA, Mullins MA: High-performance liquid chromatographic assay with eletrochcmical detection for azithromycin in plasma and tissue. J Chromatogr 1991;565:321-337.
7. Marquardt DW: An algorithm for least squares estimation of nonlinear parameters. Siam J 1963; 14: 1176-1179.
8. Gibaldi M, Perrier D: Apparent zero order absorption; in Gibaldi M. Perrier D (eds): Pharmacokinetics, ed 2. New York, Dekker, 1982. pp 84-88.
9. Gibaldi M, Perrier D: Apparent zero order absorption; in Gibaldi M, Perrier D (eds): Pharmacokinetics, ed 2. New York, Dekker, 1982, pp. 63-72.
10. Rescigno A, Beck JS: Compartments; in Rosen R (ed): Foundations of Mathematical Biology. New York, Academic Press, 1972, vol 2, pp 255-322.
11. Ripa S, Fcrrante L, Mignini F, Ecari U, Ruffilli MP: Pharmacokinetics of Bacampicillin using a compartment model with zero-order absorption. Chemotherapy 1988:34:85-89.
12. Foulds G, Shepard RM, Johnson RB: The pharmacokinetics of azithromycin in human scrum and tissue. Antimicrob Chemother 1990; 25(suppl A);73-82.
13. Guyton AC: Textbook of Medical Physiology, ed 5. Philadelphia, Saunders, 1976, p. 251.
14. Cooper MA, Nye K, Andrews JM, Wise R: The pharmacokinetics and inflammatory fluid penetration of orally administered azithromycin. J Antimicrob Chemother 1990;26: 533-538.
15. Bergan T, Jorgensen NP, Olszewski W, Zhang Y: Azithromycin pharmacokinetics and penetration to lymph. Scand J Infect Dis 1992; suppl 83:15-21.
16. Mazzei T, Surrenti C, Novelli A, Crispo A. Fallani S, Carla V, Surrenti E, Periti P: Pharmacokinetics of azithromycin in patients with impaired hepatic function. J Antimicrob Chemother 1993;3 (suppl E): 57-63.
17. Schentag JJ, Ballow CH: Tissue-Direct Pharmacokinetics. Am J Med 1991;91(suppl 3A):5-12.
18. Rowland M, Tozer TN: Clinical Pharmacokinetics: Concepts and Applications. Philadelphia, Lea & Febiger, 1980, p 44.